Podcasts about Hesham

What happens when technology levels the playing field—when education, innovation, and opportunity become more accessible than ever before? For many, AI is that transformative force, acting as the Great Equalizer across industries. Live from MWC Barcelona, host Matthew Roberts is joined by Tomer Gingold from Amdocs and Hesham Fahmy, Chief Information Officer at TELUS, to explore AI's ever-evolving impact. Hesham kicks things off by breaking down TELUS's transformation from a traditional telecom company to a tech-driven powerhouse, shifting IT from a cost center to a strategic value creator. He also highlights AI's power in education and knowledge democratization, making information more accessible while revolutionizing the way businesses operate. The discussion delves into AI's societal impact and its alignment with TELUS's mission to use technology for social good. Looking ahead, the trio examines AI's rapid adoption, shifting public perceptions, and what the next 12 months might hold. Discover how AI isn't just driving innovation—it's making knowledge more accessible than ever.

What if your biggest business breakthrough came from a completely different industry? In this episode, Dr. Hesham Baky shares how he transitioned from scaling a multi-location dental empire to building a $230M real estate portfolio focused on high-growth medical retail spaces what he calls "Medtail." Discover the game-changing strategy he used to identify prime locations before they boom, leverage real estate for massive returns, and create a fund that attracts both medical professionals and high-net-worth investors. 5 Key Takeaways from the Episode with Dr. Hesham BakyThe Power of Owning the Real Estate Behind Your Business Dr. Baky learned from a mentor that owning the real estate where your business operates provides long-term financial stability. This insight led him to acquire properties alongside his dental practices, ultimately fueling his expansion into commercial real estate.Medtail: The Future of Medical Real Estate Investment The shift of medical services into retail spaces—dubbed "Medtail"—is a high-growth trend. By placing medical offices in high-traffic retail locations, Dr. Baky has been able to create more patient-friendly experiences while capitalizing on the value of mixed-use developments.Using Heat Mapping to Predict Real Estate Growth Instead of relying solely on census data, Dr. Baky and his team developed a proprietary heat-mapping system based on future housing permits. This allowed them to identify high-growth areas before they developed, securing prime real estate at a fraction of its future value.The Benefits of a Fund Structure for Scaling Investments While initially focused on personal real estate investments, Dr. Baky realized the power of pooling investor capital. His Blue Ridge Capital Fund allows doctors and high-net-worth individuals to participate in lucrative real estate opportunities while benefiting from his expertise.Trend-Based Investing vs. Asset-Based Investing Dr. Baky's success stems from spotting emerging trends rather than being tied to a single asset class. From identifying Medtail as a rising investment opportunity to capitalizing on distressed retail centers during COVID, his ability to recognize market shifts has led to significant wealth creation.About Tim MaiTim Mai is a real estate investor, fund manager, mentor, and founder of HERO Mastermind for REI coaches.He has helped many real estate investors and coaches become millionaires. Tim continues to help busy professionals earn income and build wealth through passive investing.He is also a creative marketer and promoter with incredible knowledge and experience, which he freely shares. He has lifted himself from the aftermath of war, achieving technical expertise in computers, followed by investment success in real estate, management skills, and a lofty position among real estate educators and internet marketers.Tim is an industry leader who has acquired and exited well over $50 million worth of real estate and is currently an investor in over 2700 units of multifamily apartments.Connect with TimWebsite: Capital Raising PartyFacebook: Tim Mai | Capital Raising Nation Instagram: @timmaicomTwitter: @timmaiLinkedIn: Tim MaiYouTube: Tim Mai

Pr. Hesham Shehab of Peace Lutheran-Lombard, IL and Salam Christian Fellowship   The post The Islamic Holy Month of Ramadan – Pr. Hesham Shehab, 2/28/25 (0594, Encore) first appeared on Issues, Etc..

Josh Sebo (COO of OfferVault), Adam Young (CEO of Ringba), industry legend Harrison Gevirtz and special guest Aya Hesham (Director of Partnerships at Vivian Agency) discuss: - Vivian Agency: Why is it "women-only?" - How to launch and manage affiliate programs for your business - Do's & Don'ts of Affiliate Marketing - How to grow your business with affiliates - When is the right time to launch an affiliate program? Follow Us: OfferVault: WEBSITE: https://www.offervault.com/ FACEBOOK: https://www.facebook.com/offervault INSTAGRAM: https://www.instagram.com/offervaultmarketing/ TWITTER: https://www.twitter.com/offervault LINKEDIN: https://www.linkedin.com/company/offer-vault/ Adam Young: RINGBA: https://www.ringba.com RINGBA's INNER CIRCLE: https://try.ringba.com/inner-circle/ FACEBOOK: https://www.facebook.com/ringba INSTAGRAM: https://www.instagram.com/adamyoung/ TWITTER: https://www.twitter.com/arbitrage LINKEDIN: https://www.linkedin.com/in/capitalist Harrison Gevirtz: INSTAGRAM: https://www.instagram.com/affiliate/ LINKEDIN: https://www.linkedin.com/in/harrisongevirtz/ Aya Hesham: VIVIAN AGENCY: https://www.vivianagency.com/ LINKEDIN: https://www.linkedin.com/in/aya-elrahman-saad-799638213/

Dave travels to Cairo, Egypt, for a fascinating interview with Dr. Hesham Sallam, Egypt's leading paleontologist and founder of the country's first Vertebrate Paleontology Center. As a fellow Paleo Nerd, Dr. Sallam shares insights into his groundbreaking work, his efforts to bring more women into the field, and the thrilling discoveries shaping Egypt's prehistoric story.

In this episode of the CanadianSME Small Business Podcast, we are joined by Hesham Fahmy, Chief Information Officer at TELUS. Hesham has been instrumental in guiding TELUS through a significant digital transformation, incorporating advanced technologies like AI and cloud solutions to enhance operational efficiency and customer service. He shares insights into TELUS' journey, the impact of AI on customer support, and the ethical considerations of AI deployment.Key Highlights:Hesham describes TELUS' transition from a traditional telecom to a digital-first, software-centric organization.Discussion on TELUS' development of a GenAI-powered customer support tool.Exploration of how TELUS addresses ethical considerations and data privacy in its AI applications.Hesham offers advice to other business leaders on adopting AI technologies effectively within their operations.Hesham shares exciting future projects and initiatives that continue to position TELUS as a leader in technology and customer service.We thank Hesham Fahmy for his enlightening conversation and for sharing his expertise in driving one of Canada's leading tech transformations. His insights are essential for anyone in the tech sector or any business leader looking to embrace digital and AI advancements.Shoutout to our sponsors for more information find their links below:RBC: https://www.rbcroyalbank.com/dms/business/accounts/beyond-banking/index.htmlUPS: https://solutions.ups.com/ca-beunstoppable.html?WT.mc_id=BUSMEWAXero: https://www.xero.com/ca/?source=CanadianSMEConstant Contact:  https://www.constantcontact.com/landing1/new-marketer?utm_campaign=canadiansme&utm_medium=sponsorlogo&utm_source=brand   IHG Hotels and Resorts: https://businessedge.ihg.com/s/?language=en_USDon't forget to subscribe to CanadianSME Small Business Magazine at www.canadiansme.ca  for more insightful episodes that empower your entrepreneurial spirit.

On this episode of Pophealth Week, we feature Hesham Hessaballa MD, a pulumonary and critical care medicine specialist practicing for more than 20 years. Dr. Hassaballa is board certified in internal medicine, pulmonary medicine, critical care medicine and sleep medicine, serves as Assistant Professor Rush University & Medical Center, and Editor of the popular blog @MedikaLife keep up with Dr. Hassaballa's work on Twitter profile @HAHassaballaMD or on linkedIn, or on the web via www.drhassaballa.com. We discuss his journey into critical care medicine and explore his '11 rules for the ICU' recommendations outlined in 'How Not to Kill Someone in the ICU'. Follow Dr. Hassaballa's work on Twitter via @HAHassaballaMD, on linkedIn, or on the web via www.drhassaballa.com.

On this episode of Pophealth Week, we feature Hesham Hessaballa MD, a pulumonary and critical care medicine specialist practicing for more than 20 years. Dr. Hassaballa is board certified in internal medicine, pulmonary medicine, critical care medicine and sleep medicine, serves as Assistant Professor Rush University & Medical Center, and Editor of the popular blog @MedikaLife keep up with Dr. Hassaballa's work on Twitter profile @HAHassaballaMD or on linkedIn, or on the web via www.drhassaballa.com. We discuss his journey into critical care medicine and explore his '11 rules for the ICU' recommendations outlined in 'How Not to Kill Someone in the ICU'. Follow Dr. Hassaballa's work on Twitter via @HAHassaballaMD, on linkedIn, or on the web via www.drhassaballa.com.

Hosts Fred Goldstein and Gregg Masters MPH talk to Hesham Hessaballa MD, a pulumonary and critical care medicine specialist practicing for more than 20 years. Dr. Hassaballa is board certified in internal medicine, pulmonary medicine, critical care medicine and sleep medicine, serves as Assistant Professor Rush University & Medical Center, and Editor of the popular blog @MedikaLife. They discuss his journey into critical care medicine and explore his '11 rules for the ICU' recommendations outlined in 'How Not to Kill Someone in the ICU'. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Best Movies - Top 10  Top Movies  Salaar - very good commercial movie after a long gap Miss Shetty Mr Polishetty - except first 25 mins, Naveen Polishetty comic timing and screen presence carried entire movie and made it funny  Hi Nanna - With pure emotion director tug your heartstrings along with amazing acting and awesome BGM and songs from Hesham. Shouryuv director to watch out for 35 crores share  Samajavaragamana - my favorite type of movie, switch of son helping his father getting a degree was hilarious along with rakhi scenes and whole Vennela Kishore track. Except last 15 mins, hilarious movie Need more movies like this. Clean family entertainers.  MAD - hilarious movie with funny one liners. Friendship, beautiful girls, catchy songs, what else do you want from a youth movie. Sangeeth Sobhan next big talent in Telugu cinema.  Bhagavanth Kesari - unexpected movie from Ravipudi and Balayya, 0 cringe with a good message about women empowerment along with presentation of Balayya and elevations and commercial elements, it was a refreshing movie to see Balayya play his age and design mass within that.   Balagam - comedy was great but lot of melodrama. However it showed culture in a great light  Writer Padmabushan - idgaf what anyone says, movie was great and I laughed a lot. Clean movie  Virupaksha - I didnt like it it was so weird but the sound design, cinematography, direction, BGM, and production design were all outstanding. A genre movie 100 crores range ante its huge.  Bedurulanka - interesting and funny movie about exploitation of society with village heads conning people  Worst 5  Skanda - rod, so much athi,  Veera Simha Reddy - worst writing and worst fights and worst story and flashback, such a fucking boring movie  Dasara - boring fucking movie except climax  Baby - Anand is a pussy, Vaishnavi is a bigger pussy, and Viraj is the biggest pussy  Adipurush - Watch Chota Bheem or Hanuman with Chiranjeevi, it's way better  Special mention: Waltair Veerayya not Chiru range movie and acting was very artificial very overrated movie bad album and then Boss saying hey have 2.25 ratings but we did 2.25 million,   Rangabali, Kushi, Tiger Nageswara Rao, Bro, Mem Famous, Anni Manchi Sakunamule - Nanindi Reddy said my film will have a self life of 25 years despite the bad talk. Nobody will watch it again.  Top 10 Songs: Needhe Needhe - from Hi Nanna  Samayama - Hi Nanna  Ye Vaipukuki Saguthondi from Miss Shetty  Dum Masala from Guntur Kaaram Lady Luck from Guntur Kaaram  Swaasa Meeda Dyaasa - Keeda Cola  Ram Sita Ram from Adipurush  Priya Mithunam from Adipurush  Aradhya from Kushi  Adigaa from Hi Nanna  Worst Songs of the year: Poonakallu Loading from Waltair Veerayya, Cult Mama from Skanda, Ole Ole Pappayi from Extra Ordinary Man  Awards  Hero of the year: Prabhas two highest grossing movies but result wise Adipurush disaster and then Salaar TBA  Best film - Salaar  Best Director: Prashanth Neel for Salaar  Special mention: Ram Abbaraju for Samajavaragamana  Best Actor - Naveen Polishetty for MSMP  Special Mention: Nani for Dasara  Best Actress: Mrunal Thakur  Special Memtion - Samyuktha Menon for Virupaksha  Best Debut Male - Sangeeth Sobhan for MAD  Best Debut Actress - Vaishnavi Chaitanya for Baby  Song of the Year - Needhe Needhe from Hi Nanna  Singer of the year male - Karthik (Nachavule, Adipurush 2 songs, Anni Manchi Sakunumule title song, Adigaa Hi Nanna)  Singer of the year female - N/A  Best Supporting Actor: Naresh for Samajavaragamana, Raviteja for Waltair Veerayya  Best Supporting Actress: Rohini for Writer Padmabushan  Best Cinematography: Sathyan Sooryan for Dasara, Bhuvan Gowda for Salaar  Worst movie: Bhola Shankar, Agent and Veera Simha Reddy Worst Director: Meher Ramesh, Surender Reddy and Gopichand Malineli  2024 Preview  Guntur Kaaram  Saindhav  Devara  Pushpa 2  Kalki 2898  Game Changer  OG  Ustaad Bhagat Singh  Hari Hara Veera Mallu  Saripodha Sanivaaram  VD12 

Impression: All-Ohio First Team Urologist Dr. Hesham Mostafa describes to Saad and Travis his journey growing up in Cleveland to parents of Egyptian descent, attending The Ohio State University, graduating from the University of Cincinnati College of Medicine and completing Urology residency at the University of Toledo Medical Center specializing in robotic and minimally invasive surgery before practicing in Northwest Ohio.

Payman chats with Hasham Ali about his journey from the Middle East to Manchester, UK, where he now practices as a specialist orthodontist.    Hesham discusses the value and challenges of professional networking, what it takes to turn GDPs into competent orthodontists, and why the term specialist orthodontist will always be a secondary identity.     In This Episode 02:00 - Specialising 08.04 - The UK, NHS and private work 12.15 - Networking, communication and social media 24.57 - Teaching and events 28.28 - Roots and relationships 37.15 - Ortho training, planning and treatment 57.35 - Blackbox thinking 01.02.54 - Knowing Vs not knowing 01.06.05 - Orthodontics and health 01.11.06 - Dark days 01.21.21 - In retrospect 01.22.55 - Free time 01.25.24 - Being a twin 01.27.58 - Fantasy dinner party 01.35.49 - Last days and legacy About Hesham Ali Hesham Ali is a specialist orthodontist and consultant at the Royal Bolton Hospital in Greater Manchester. He also teaches orthodontics through his Orthodontia brand.  

هاني مدبولي شريك و مدير شركة أوف رود إيجيبت المتخصصة في تعديل سيارات الدفع الرباعي و الملاح في فريق رحالة للسباقات يت. و هشام فاروق  مدير التصوير السينمائي و عاشق للصحراء و احد روادهاProduced by: Abbas Aboelhassan Chapters00:00 Intro00:27 فريق رحالة06:03 الف كيلو على الحصان13:42 رالي الفراعنة21:15 موسم الصحراء37:54 الخبرة هي الأساس58:50 الدعم والسياحةFollow: rwa.podcast.egInstagram: https://www.instagram.com/rwa.podcast.eg/Facebook: https://web.facebook.com/rwa.podcast.egTwitter: https://twitter.com/rwa_podcast_egTiktok: https://www.tiktok.com/@rwa.podcast.egFollow Abbas Aboelhassan: Instagram: https://www.instagram.com/abbasaboelhassanofficial/Facebook: https://web.facebook.com/AbbasyzListen to our podcast: https://www.buzzsprout.com/1248233#rwapodcast #abbasaboelhassan #podcast #rantswithabbas

Host Gil Bashe chats with Rush based and board Certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Medicine, Dr. Hesham A. Hassaballa, a Fellow of the American College of Physicians and author of "How Not To Kill Someone In The ICU: A Practical Guide For A Successful Rotation, Or Career, In The Intensive Care Unit." Dr. Hassaballa has a strong interest in the integration of spirituality and medicine, and he has written extensively on this topic. He is the author of several books, including ""The Believer's Guide to Ramadan"" and ""The Beliefnet Guide to Islam."" His writings have been featured in various publications, including the Huffington Post, Chicago Tribune, and the Washington Post. Book Link: https://www.amazon.com/How-Not-Kill-Someone-ICU/dp/0985326514 To keep tabs on Dr. Hassaballa follow on twitter via @HAHassaballaMD or on the web at www.drhassaballa.com To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

We've all heard of the Arab League, but we wanted to know more about its history, intended purpose and its inner workings. Ambassador Hesham Youssef joined us for a fascinating conversation about foreign-affairs, Arab geopolitics, and to help us better understand this key regional institution.In this episode, we cover the history of the Arab League, its activities and impact, and what Ambassador Youssef predicts for the future of our region.Ambassador Hesham Youssef was a career diplomat, posted to Canada and the Egyptian Mission in Geneva during his time at the Egyptian Foreign Ministry. He went on to work at the Arab League and now works at the Organisation of Islamic Cooperation.He has extensive experience working in conflict resolution in the Middle East, with particular focus on the Arab-Israeli conflict, reconciliation in Iraq and the situation in Sudan. He has also worked on economic and trade issues with the UN and the WTO.Created & Hosted by Mikey Muhanna, afikraEdited by: Ramzi RammanTheme music by: Tarek Yamani https://www.instagram.com/tarek_yamani/About the afikra Conversations:Our long-form interview series features academics, arts, ‎and media experts who are helping document and/or shape the history and culture of the Arab world through their ‎work. Our hope is that by having the guest share their expertise and story, the community still walks away with newfound curiosity - and maybe some good recommendations about new nerdy rabbit holes to dive into headfirst. ‎FollowYoutube - Instagram (@afikra_) - Facebook -Twitter Support www.afikra.com/supportAbout afikra:‎afikra is a movement to convert passive interest in the Arab world to active intellectual curiosity. We aim to collectively reframe the dominant narrative of the region by exploring the histories and cultures of the region- past, present, and future - through conversations driven by curiosity. Read more about us on  afikra.com  

لقاء مع الفنان القدير هشام عبد الله من المنفى فى تركيا. لماذا شارك فى الثورة وكيف ترك مصر وماذا حدث عندما اختطفته المخابرات الحربية 6 ساعات اثناء الثورة.

We know the ‘system' has challenges and in many ways is responsible for the way we work with or against each other, knowingly or unknowingly. Can quality improvement approaches help sustain our reasons for being in healthcare? FURTHER LEARNING If you're a member of Medical Protection and want to learn more: Understanding human factors to improve clinical performance and patient safety [Recorded Webinar] https://protection.pub/3CE4y7z Introduction to Human Factors [eLearning] https://protection.pub/3Nj6SWx For more information about the Patient Safety Incident Response Framework & Hexitime https://www.england.nhs.uk/patient-safety/incident-response-framework/ https://vimeo.com/617883668 https://www.youtube.com/watch?v=9FL1E6KZ4Ak CERTIFICATE A certificate of learning for listening is available on PRISM https://protection.pub/3WtX54j SPEAKERS Our host today was Dr Najeeb Rahman Our guest speaker today was Dr Hesham Abdalla For more information about Medical Protection please visit www.medicalprotection.org

Please join Guest Host Maryjane Farr, authors Sarah Franklin and Stavros G. Drakos, as well as Associate Editor Hesham Sadek as they discuss the article "Distinct Transcriptomic and Proteomic Profile Specifies Heart Failure Patients With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support." Dr. Carolyn Lam: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. We're your cohosts. I'm Dr. Carolyn Lam, associate editor from the National Heart Center in Duke National University of Singapore. Dr. Peder Myhre: And I'm Dr. Peder Myhre, social media editor from Akershus University Hospital and University of Oslo. Dr. Carolyn Lam: Peder, today's featured paper is very, very important in the heart failure world. It is such a deep dive into the transcriptomic and proteomic profile that specifies heart failure and the potential of myocardial recovery with mechanical unloading and circulatory support. Dr. Peder Myhre: Can't wait for that feature discussion today, Carolyn. Dr. Carolyn Lam: But you have to wait because I insist on telling you about yet another really important paper, of course in my favorite subject, heart failure with preserved ejection fraction or HFpEF. Now you know that exercise intolerance is a defining characteristic of HFpEF and a marked rise in pulmonary capillary wedge pressure during exertion is pethepneumonic for HFpEF and it's thought to be a key cause of the exercise intolerance. Now if that is true, acutely lowering the wedge pressure should improve exercise capacity, right? Well, don't assume this because to test this hypothesis, authors led by corresponding author Dr. Ben Levine from UT Southwestern evaluated peak exercise capacity with and without nitroglycerin, which was used to acutely lower pulmonary capillary wedge pressure during exercise in patients with HFpEF. Dr. Peder Myhre: Oh, that's so cool. What an amazing research question and Carolyn, you're the best to summarize this. Please tell us what did they find? Dr. Carolyn Lam: Well, they studied 30 patients with HFpEF and get this. They underwent two bouts of upright seated cycle exercise dosed with sublingual nitroglycerin or a placebo every 15 minutes in a single blind randomized crossover design. So really well done. Wedge pressure, VO2 and cardiac output were assessed at rest with 20 watts exercise and at peak exercise during both the placebo and nitroglycerin conditions and the principle finding of the study (singing) acutely lowering pulmonary capillary wedge pressure during upright exercise with nitroglycerin in HFpEF did not improve peak exercise performance. So peak VO2 was practically identical with a 1% difference despite a 17% drop in peak wedge pressure. Peak cardiac output and peak peripheral oxygen extraction were unchanged, again, despite the drop in peak wedge pressure suggesting that oxygen delivery and utilization were unaffected. Exercise performance variables including peak wattage, peak ventilation and peak RER were unchanged, suggesting that again, reductions in peak wedge were insufficient to improve exercise tolerance. All these results suggest acute reductions in wedge pressure are insufficient to improve exercise capacity and provide convincing evidence that a high wedge during exercise by itself is an epiphenomenon perhaps rather than a primary limiting factor for exercise performance in patients with HFpEF. Now of course this is incredibly interesting contrary to hypothesis and so please read the paper. The discussion is very rich. Dr. Peder Myhre: Oh wow, Carolyn. That is such a great paper. I can't wait to pick it up and read it from start to finish and now Carolyn, we're going to look into research within cardiovascular disease from COVID-19 and we have learned so much and so quickly about COVID-19 and its effects on the heart and we have really come a long way from the first case reports reported in the beginning of the pandemic and this paper, which comes to us from corresponding author Professor JP Greenwood, really adds important knowledge to this field. The COVID heart study was a prospective longitudinal multi-center observational cohort study of patients hospitalized with COVID-19 and at elevated serum troponin levels across 25 hospitals in the UK and these investigators aim to characterize myocardial injury, its association and sequela in convalescent patients following hospitalization with COVID-19 utilizing appropriately matched contemporary controls. Dr. Carolyn Lam: Ooh, important stuff. So what did they find? Dr. Peder Myhre: So these authors included in total 519 patients comprising 342 patients with COVID-19 and an elevated troponin, 64 patients with COVID-19 and a normal troponin and 113 age and comorbidity matched controls without COVID-19 and the frequency of any heart abnormality defined as left or right ventricular impairment, scar or pericardial disease was two full greater in patients with COVID positive and troponin positive, so 61% compared to the control groups and that is 36% for COVID positive and troponin negative and 31% for COVID negative and comorbidity positive and the myocardial injury pattern was different for these patients with COVID and an elevated troponin more likely than controls to have infarction and micro infarction. But there was no difference in non-ischemic scar and using the late MRI criteria, the prevalence of probable recent myocarditis was almost 7% for those with COVID and elevated troponin compared to only 2% for the controls without COVID-19 and myocardial scar is but not prior COVID-19 infection or troponin was an independent predictor of MACE. So Carolyn, these authors discussed their findings in light of previously reported studies and these authors identified a lower prevalence of probable recent myocarditis than previously described and a higher proportion of myocardial infarction and this newly described pattern of micro infarction following COVID-19 and Carolyn, there is a brilliant editorial really summarizing this by Dr. Stuber and Baggish entitled "Acute Myocardial Injury in the COVID Heart Study Emphasizing Scars While Reassuring Scarce." I really recommend everyone to pick this up and read the editorial as well. Dr. Carolyn Lam: Very clever title. Thank you. For the last original paper in today's issue, it focuses on the crosstalk between sterile metabolism and inflammatory pathways, which have been demonstrated to significantly impact the development of atherosclerosis. Authors today are featuring and focusing on 25 hydroxy cholesterol, which is produced as an oxidation product of cholesterol and belongs to a family of bioactive cholesterol derivatives produced by cells in response to fluctuating cholesterol levels and immune activation. So these authors with co-corresponding authors, Dr. Suárez and Fernández-Hernando from Yale University School of Medicine, they showed beautifully that first, 25 hydroxy cholesterol accumulates in human coronary atherosclerosis. Next, that 25 hydroxy cholesterol produced by macrophages accelerated atherosclerosis progression and promoted plaque instability by promoting the inflammatory response in macrophages and also via paracrine actions on smooth muscle cell migratory responses. Dr. Peder Myhre: Wow, that is so interesting, Carolyn. What are the therapeutic implications of these findings? Dr. Carolyn Lam: Yes, I'm glad you asked because it was summarizing a lot of work in those findings with the very important implications that inhibition of 25 hydroxy cholesterol production might therefore delay atherosclerosis progression and promote plaque stability. So this study actually opens a door to explore the role of 25 hydroxy cholesterol as a target to control inflammation and plaque stability in human atherosclerosis. Dr. Peder Myhre: Oh, that is so important. Thank you so much and there is more in this issue as well, Carolyn. We have another issue of Circulation Global Rounds and this time we're going to France in a paper written by Dr. Danchin and Bouleti. We also have an exchange of letters by Dr. Yang and Dr. Schultze regarding the article, "Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation" and an ECG Challenge by Drs. Manickavasagam, Dar and Jacob entitled "Syncope After Transcatheter Aortic Valve Implantation: Pace or Not." Dr. Carolyn Lam: Interesting. There's a Frontiers paper also by Dr. Dimopoulos on “Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus,” a Research Letter by Dr. Kimenai on the impact of patient selection on performance of an early rule out pathway for myocardial infarction from research to the real world. Nice. Well let's carry on to that feature discussion on heart failure, transcriptomics and proteomic, shall we? Dr. Peder Myhre: Can't wait. Dr. Maryjane Farr: Welcome everybody to Circulation on the Run. We are so pleased to be talking with Dr. Stavros Drakos and Dr. Sarah Franklin from the University of Utah. My name is Maryjane Farr and I am the heart failure section chief at UT Southwestern and Digital Strategies editor for circulation. Myself and Hesham Sadek will be talking with them about their new paper and circulation called "Distinct Transcriptomic and Proteomic Profile Specifies Heart Failure Patients with Potential of Myocardial Recovery Upon Mechanical Unloading and Circulatory Support." Just briefly, Dr. Stavros Drakos is the director of cardiovascular research for the division of cardiology at Utah and co-director of the Heart Failure Mechanical Circulatory Support and Heart Transplant Program. Dr. Sarah Franklin is associate professor of medicine at the University of Utah whose lab has a specific expertise in the applications of proteomics to heart disease. Welcome, Stavros and Sarah. Dr. Sarah Franklin: Thank you. Dr. Stavros Drakos: Thank you. Thank you for having us. Dr. Maryjane Farr: This paper is exciting for clinicians. It's exciting for translational scientists. Hesham, why don't you start digging into this paper and tell us one or then the other of you tell us what this paper is about, what's the background and let's get into the science. Let's go there and then we'll pull back and look at some of the big picture stuff. Hesham. Hesham Sadek: Well, thank you. So I've been fascinated by the field of cardiac recovery for some time now and obviously Stavros is as an expert and one of the leaders of that field and what struck me about this is that we are starting to see some distinct molecular signature of patients that can experience recovery as opposed to patients undergoing the same procedures with the same profile that do not manifest evidence of myocardial recovery and specifically, the study was conducted very rigorously and the signature was very clear in that they saw primarily interest for someone like me who's interested in cardiac regeneration, a signature of cell cycle in the patients that experience recovery as well as ECM signature which could suggest reverse remodeling and also there's some evidence that ECM might impact cardiomyocyte and myocardial regeneration. So my interest in this for selfish reasons is primarily that this supports the hypothesis that perhaps there is a molecular signature of regeneration that occurs in patients that experience myocardial recovery with LVAD. Dr. Maryjane Farr: So Stavros, let's start with you. Give us the reason why to do this study. You mentioned some of the background. It'd be great to sort of talk for a moment about re-stage heart failure and then how it brought you to this study. Dr. Stavros Drakos: Thank you, Jane. So again, thank you for the opportunity to talk about the findings and the implications of this study. I like the way you are asking us to look a little bit at what led to this study and as you mentioned, the re-stage is a multi-center study that was performed in six US sites which showed in a reproducible fashion now given that we had single center studies from all over the world suggesting that, advanced heart failure is not an irreversible process that has to lead to end stage, an irreversible disease and what a re-stage demonstrated was that there is a subset of patients which if you select them based on clinical characteristics that we derived from other studies that were performed previously, you can achieve reverse remodeling, essentially a bad heart looking much better by every clinical, functional, structural characteristic in up to 50% of the selected patients. That's what re-stage showed. So having this finding now in a multicenter study, what made this study very timely was to be able to understand what drives this remarkable response. What are some of the mechanisms, as Hesham said, that we can if uncover take advantage of and expand this paradigm and enhance it and achieve reverse remodeling and recovery of even more patients and even go earlier in the disease process. So that's kind of how I would link the clinical findings that preceded this study with the motivation to perform the study and the implications of these findings for the ongoing translational and basic science research. Hesham Sadek: I'd like to ask a question here. So Stavros, do you think it's too early to sort of redefine the term reverse remodeling in this context to include perhaps some evidence of regeneration? Is there evidence of regeneration in this field or that's too premature to say? Dr. Stavros Drakos: I think the data are directing us towards the direction you just mentioned. I think that we can begin talking about it and planting the seed. We do have other evidence from work that you and others have performed indicating that this indeed is one of the mechanisms that drives this phenomenon and I think that the findings, especially in the cell cycle that we identified add to and contribute even more to that body of work that you and others have done. At this point, I will turn it to Sarah who can talk a little bit more about the findings related to the cell cycle that we identified in our study and I think that these may complete the answer to you, Hesham. Dr. Sarah Franklin: Yeah, I would love to comment. I think it's a really interesting phenomenon and really in these patient samples we were trying to understand molecularly what the difference is between individuals that respond positively to therapy and individuals that receive the same exact therapy and do not respond positively. So these are termed responders and non-responders and in our analysis we combined two platforms where we could molecularly interrogate what's different in these two tissues and try to see what is differentiating these populations. So what's consistent and reproducible different in responders and non-responders on a molecular level and in both the transcriptomic data and the phospho proteomic data, we saw clear patterns with cell cycle regulation and extracellular matrix or focal adhesion molecules and the interesting thing about cell cycle is cardiomyocytes have typically been thought to exit the cell cycle not long after birth and we see some interesting phenomenon either in humans or mice where we can have nuclei that have either multiple sets of chromosomes or multiple nuclei and there's some differences that have been observed in the nucleus with regards to disease, so hypertrophy, heart failure. So the molecules that we've identified, we saw a large difference in proteins involved in cell cycle regulation. Now the interesting thing is not all of those molecules are increasing or decreasing. We see a combination of molecules that are increasing or decreasing. But I think the other thing that's interesting is that these molecules, even though we are seeing changes in expression or changes in phosphorylation, exactly how that contributes to either cell cycle or cell cycle reentry or just nuclear function and transcription of proteins or genes or DNA regions is still what we need to continue to study. So exactly how these changes in proteins or transcripts related to the cell cycle, how they are exactly contributing to the physiological improvements that we're seeing is something that still needs to be investigated but is really important that that is a highlight of this study and as Stavros mentioned of previous work. Dr. Maryjane Farr: Stavros, tell us the design of the study. Dr. Stavros Drakos: Okay. So this study was performed in 93 patients that were prospectively enrolled in the Utah transplant affiliated hospitals here in Salt Lake City between the University of Utah, Intermountain Medical Center and the VA and these people came from all over the mountain west, the surrounding states of Utah and through our VA, through the state, from all over the west and south, from Alaska and Hawaii to Texas and we think it's a very representative population of our country's patient population and then we followed prospectively these people with serial echocardiograms so we can tell who will respond as Sarah said before, which essentially means which hearts are going to get better by echocardiographic criteria functionally and structurally, the dimensions of the heart shrinking and the ejection fraction improving to more than 40% and the dimension shrinking to normal range and then we compare these people, the subset of patients that have responded to the majority of patients actually that they have not responded. As we know these are advanced end stage patients and there is only a subset of those that they will favor respondents. As we said earlier, these subset can increase if you go selectively and pick these patients based on baseline characteristics. So then we analyze the tissue we got from these people when the LVAD went in, which is the core of the apex of the heart and compare that to the tissue we receive when the patients got transplanted and we got the whole heart. So in the meantime, as we just discussed, we phenotyped these people so we knew who were responders and non-responders and then we went back in the lab and tried to marry two basic processes, analyzing the transcriptome and the proteome and by doing that we were able to see some overlapping changes between the transcriptome and the proteome and we felt that by doing this overlapping analysis, we will increase the likelihood that what we are seeing, exponential mechanistic drivers will be the real mechanism and not just associations that you can frequently find when you do studies in humans and that's kind of a rough, brief summary of the design. Sarah, would you add something to that? Dr. Sarah Franklin: No, I think that's a great overview of it. I think what excites me about it is that this was first clinically observed that these patients were recovering and so I think the exciting part is the hypothesis was that there was some molecular underpinnings that could molecularly define these patients that were responding or not responding and so with that hypothesis we then carried out these analyses hoping that we would see a difference and we're very excited. It's very successful in that we found very clear, molecular differences that are reproducible between these patient populations. Dr. Maryjane Farr: So obviously there's lots of implications. Let me start with one very simple clinical one and that is, so based on some of the differences in the signatures and pathways that you saw for the next patient who needs LVAD therapy and you're trying to predict in some way whether they may be a responder or a non-responder, could you look at a biopsy sample and try to make some sort of prediction based on some of your findings so that they can choose a VAD over a transplant? That's a very clinical question and then I guess the second question is would it have to be a left ventricular myocardial sample? So are the differences? What do you think about that question? Or it's just too much too, far beyond? This is obviously a mechanistic study. But I'm just asking. Dr. Stavros Drakos: No, that's a great question and I'll start and Sarah can add later. So obviously it will be great if we can have a practical way to predict before the intervention who are the people that they will respond and that's one of the motivations for this study. It was not just to find the mechanism so we can make this phenomenon better and enhance it and find the mechanism, create new therapies. It was also the practical approach that you suggested, Jane, and I think that yes, this adds to the clinical predictors that we have already identified from other studies and yes, we could theoretically take the tissue and do this analysis. Is this the most practical thing we can say to the patient to biopsy the heart, right? It would've been better to be able to identify a biomarker in the plaque and we've done that. We started in other studies, identifying what's going on in the tissue and then going targeted in the blood and that's how we identified two cytokines and a two cytokines model, interferon gamma and TNF alpha being predictive as circulating biome. In this study we identify changes that can also inform future studies of biomarkers in the blood. But if we had a way to easily get the tissue and analyze the genes, yes, we could have done that as a predictor as well. The practical issue is that asking a patient for a biopsy just to predict the response to therapy may be something that most patients and most clinicians will consider way too advanced and complicated, right?that's why more work should and could be done to identify circulating biomarkers or other modalities that can help us interrogate what's going on in the heart related with these findings. But not that we cannot also do what you said. It's just more complicated. I don't know if Sarah would like to add to this. Dr. Sarah Franklin: I'd love to. I think that's a great overview. I think the only thing that I would add is that there are a number of conditions whether in the heart or otherwise in the body that you can use a single biomarker and it can be very predictive of conditions. Heart failure is so complex that often individual biomarkers are not sufficient enough to cover an entire population and all the nuances that can go into heart failure symptoms or syndromes and I think the exciting part about this study is it is one of the largest cohorts of patients that have been examined in this manner, which is exciting, but also that we have a multi-factor panel that is made up of multiple biomarkers that with the number of individuals that we examined is completely predictive of all of these patients. So these biomarkers are consistent and reproducible across all of these patients between responders and non-responders regardless of some of the nuances in the heart failure that they have and so it's very exciting because it's possible that a multifactorial panel could be much more applicable and last the test of time more so than an individual biomarker. I think the one other thing that is exciting like Stavros mentioned is that we did initially identify these in the left ventricle and it will be really exciting to see how far these biomarkers can be used if they can be used in potentially other aspects of the heart or blood, which obviously is less invasive and so that's not something that we've applied this panel to yet, but I think is a really wonderful extension of now saying, can we also identify some of these biomarkers in the blood which would be less invasive even if it's a fraction of them. That would still be wonderful. Dr. Maryjane Farr: I have so many clinical questions. But Hesham, what questions do you have? Hesham Sadek: Yeah, so the elephant in the room here obviously is that the variable is that these patients have an unloaded heart and there is evidence that unloading can reverse some of the changes that occur after birth with increasing ventricular load and initiate cascade of molecular events that may allow myocytes to proliferate. So this begs the question, is there a difference in how these ventricles of patients that recover versus those that do not recover see load? Are we able to measure load appropriately and is there a difference in load between these patients and if so, can this be improved or detection or measuring unloading or the degree of unloading clinically, can this be improved? Dr. Stavros Drakos: No, that's a great question and it provides the opportunity to talk about some of the things we can do on the clinical arena to further enhance this phenomenon. Yes, there are ways that we can use to tailor the mechanical unloading that we can provide in order to enhance this phenomenon. One way, and that's a study that we are proposing, is to use sensors, pressure sensors that can guide the way you function the machines, the devices, right? The way you remove part of the load and these sensors, some of them are clinically approved like cardioments and then without doing invasive procedures you can follow chronically how these patients are being unloaded and how the heart is responding to this unloading. We know that a lot of LVAD patients, despite doing clinically well, we know this from snapshot evaluations in right-heart cath studies, they are not optimally unloaded. They are feeling pressures left and right are not always optimized and so by doing this kind of prospective assessment of the mechanical unloading, you can tailor what you offer and the hypothesis generated is that by doing that you may be able to recover even more people. You can do this as we said, with approved sensors like cardioments or with other sensors that they are under investigation. You can also do more invasive stuff like PV loops. Of course these will require cathing these patients, which is a little bit more complicated. But it will provide more accurate assessment and it will also interrogate how the heart is improving and provide to you in-depth investigation and in-depth insights on also how the recovery process and the reverse remodeling process is being, I would say, digested by the heart and translated to functional response instead of just looking at it with an echocardiogram or the findings of a right-heart cath and these are studies that others have performed and have published and we know that they can give you a real good look into the systolic and diastolic function of the heart and how this is changing and improving down the road. So yes, that's the short answer. We can do that and we can tailor the unloading and potentially that's the hypothesis, maximize the effect that we saw here. Hesham Sadek: So this begs the question, maybe two questions here. One, is there evidence that patients who recover not from this study only but from other studies, is there evidence that patients who recover are more unloaded than patients that do not recover and the second question is: is it time to standardize assessment of mechanical load in patients with LVAD, especially those that will undergo or would be considered for recovery? Dr. Stavros Drakos: Yes. So that's a great opportunity to share with our audience what we know and what we don't know in this field in relation to your question about whether we know what is the optimum degree of unloading and the answer I think is that we need to know and understand more. What do I mean by that? There's this idea that the heart as every other organ after being unloaded and not working for some time may it lazy, may get atrophic and may need some rehab like the skeletal muscle when we put it in the cast and get atrophic and we need to rehab it when we remove the cast. So you can imagine that the LVAD and the unloading that provides, which in many cases may take over a significant part of the function of the heart may need gradual reloading as a second phase after the first phase of unloading and that's something that we've done. We have an ongoing study on this and also others have published that it may be beneficial. Of course, it needs to be validated and investigated further and to discuss about the degree of unloading in the first phase and what is the optimum degree of unloading, I would say even there, there is room for us to understand better what's going on and I think that we can investigate with ongoing studies right now whether full unloading versus partial unloading and measure the pressures using these sensors can translate to better changes functionally and structurally. I think that's something that is very doable and it would be very beneficial. What was the second part of your question, Hesham? Hesham Sadek: I was asking whether it's time to start standardizing some measure of unloading if these patients are planned for recovery? Dr. Stavros Drakos: Yes, and that's what we are doing. In all of these people, we report from the get-go what is their recovery score based on the intermixed ICARS derived score and when we have patients that they have high likelihood of recovery, we monitor them very closely and clinically what we do is just looking at the echo and whenever we do a right heart cath for clinical reasons. But in a prospective research study we could do more than just looking at the echo and occasional right heart cath and using the sensors we just discussed previously, you can tailor the unloading and begin prospectively unloading them in a more I would say well monitored wave. Yes. Hesham Sadek: So this is unloading or device specific parameters. Now are there patient specific parameters with regards to type of heart failure? So we talked initially about whether there's an element of regeneration specifically when it comes to cell cycle. But many patients with non-ischemic cardiomyopathy for example, don't have large scars and don't have lot of myocytes as the underlying cause of cardiomyopathy. Would you foresee that there is different mechanisms, for example, in these patients that don't have myocyte loss, that perhaps maybe it's not cardio myocyte proliferation and not regeneration? Dr. Stavros Drakos: Yes. So I think that the differential responses we get based on the heart failure theology warrant further investigation. Sarah and I have discussed that and actually we are following on our findings with larger number of patients so we can tease out these and I'll let Sarah talk a little bit more about it in a minute. But to answer the clinical part of this question, we don't know yet whether different parts of heart failure should be prescribed different modes of unloading. But the way you described it of course invites the hypothesis that of course different substrates, different injuries of the heart, as you said, it's a completely different failing heart if you have a big scar there versus a patient who has a mode of heart failure, another type of injury and would this be treated better and more effectively in terms of reverse remodeling by applying a different mode of unloading? That's things that we need to investigate further. But Sarah, would you like to comment on the potential on the effect of the different heart failure theologies on some of the findings we saw? Dr. Sarah Franklin: Yeah, definitely. So I think it's a really interesting question and in this analysis we included ischemic and non-ischemic samples in the patient populations and really we're just stratifying them based on responders and non-responders. When we start layering additional levels onto that, then we're effectively kind of reducing the potential numbers. So if we have 25 responders and we start breaking that down into ischemic and non-ischemic to see if there's another layer of biomarkers there, we actually did that we did not include it in this study. It's something that we're working on to add that. But we do reduce the number overall of patients in those two populations. So it would be fine to share that we were seeing stratification between ischemic and non-ischemic. But we did not feel like the numbers might be high enough within the responder and non-responder categories that warrant including that in this manuscript. So it's very intriguing that just responders and non-responders alone stratify as well as they do. They separate based on these biomarkers and it looks like it will also be possible in the future for us to even separate these samples further based on similar or additional biomarkers based on more specific factors in the etiology. So I think that will be another really exciting next step for future research. Hesham Sadek: My final question would be maybe a little bit broader than LVAD population, but definitely informed by this study. The term non-ischemic cardiomyopathy, do you think it's too broad and too vague for us to use in this setting because this encompasses many different types of cardiomyopathy that really are not nuanced enough by this definition. Dr. Stavros Drakos: Well, Jane was smiling while you were asking this question because we all as heart failure clinicians need to accept that it was not a good idea to name all of these different diseases non-ischemic cardiomyopathy when we did it or when this happened many moons ago. As you said, Hesham, and I couldn't agree more, these are completely different diseases. We need to understand them better and I think that the way we treat nowadays, chronic heart failure, many years down the road when people will look back, they will consider it a little bit, I would say, surprising that we were treating all of these the same way. We need more studies like the one we just did, that they will have enough numbers and that's when the issue becomes that you need enough numbers to be able to tell the differences between all of these non-ischemic cardiomyopathy types, theologies and if you go upstream, motivated and inspired by findings like this, we hope that we will be able to identify how to go and do a root cause analysis and treat these diseases, not down, down, downstream the same way, but going upstream, finding what really went wrong and treating them earlier in the molecular or other pathophysiological mechanism pathway that led to the heart failure and so yes, it was a bad idea to do that. But of course sometimes we do things because we don't understand it better, right? As one of our keynote speakers here in the recovery symposium said a few years ago, Jay Khan, the founder of Heart Failure Strata of America, some things look complicated until you understand them. Then when you understand them, they look simple. So here we don't really understand non-ischemic cardiomyopathy and how all these theologies lead there and I think studies like these can help us really inform the field better. But we will need, as Sarah said, more numbers. Dr. Maryjane Farr: So that was a great conversation. I wanted to just raise one last thing and that is what's so interesting about this cohort relative to re-stage heart failure is these were older patients and for re-stage heart failure, I think the average age was 35. So you would imagine there might have been one etiology for cardiomyopathy, uncontrolled hypertension or peripartum. But for cohorts in their fifties, there's probably an accumulation of different insults over many years time and so I thought that was particularly interesting from the point of view of that you were probably dealing with, again, a mixed bag of pressure overload, volume overload, maybe a genetic underpinning, whatever the life trajectory of some of these patients were and then lastly, the decision to try to go to recovery rather than to transplant, which would be the real world experience of why this wet pathway than the other. These are people truly in their fifties where they may have one or two surgeries in their lifetime left and so it's the relevant population that you're studying and so I'll leave it at that. That's a comment rather than a question, I think. But I think for heart failure clinicians, this is why the bench to bedside piece is so relevant to understanding this because it actually does change clinical practice, even if the mechanistic pathways may take still many more years to truly understand. It helps understand what's possible from an accrued clinical decision-making level. Dr. Sarah Franklin: Jane, if I might just comment on that, I actually think that's one of the most exciting parts about this dataset is that, as you mentioned, these patients have complex diseases. They are older. But yet we are still able to see consistent and reproducible differences between the patient populations that respond and don't respond and to me that suggests that at the end of the day there are consistent differences or reproducible or consistent molecular changes in cardiac tissue and in response to stress and I think that that gives us hope that we could potentially not only predict who would respond or not respond, but that as we get better at understanding the differences, that there could be potential therapeutic targets or therapies that would still be beneficial regardless of the complexity of the heart failure. Dr. Maryjane Farr: Okay. So Sarah, Stavros, thank you so much for spending time with Hesham and myself and look forward to EUCORS--I'm allowed to say that. Dr. Stavros Drakos: Of course. Dr. Maryjane Farr: Thanks so much. Bye. Dr. Greg Hundley: This program is copyright of the American Heart Association 2023. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, please visit ahajournals.org.

هشام نزيه ملحن و موسيقي مصري وأحد أشهر وأهم مؤلفي الموسيقى التصويرية للأفلام والدراما التلفزيونية وحائز على العديد من الجوائز . ألف أول موسيقى تصويرية عام ١٩٩٨ لفيلم "هيستيريا"، ثم تلاه بعدد زاخر من الأعمال المهمة كفيلم "الساحر" و "إبراهيم الأبيض” التى شكلت موسيقاه فيه نقلة نوعية في مسيرته والموسيقى التصويرية المصرية و “تراب الماس “  و” الفيل الأزرق “ ، كما ألف موسيقى  مسلسلات "نيران صديقة" ، و"السبع وصايا” و” أفراح القبة “ . ازدادت شهرة هشام نزيه وأصبح من أكثر الشخصيات الفنية شهرة إثر تأليفه الموسيقى التي رافقت موكب نقل المومياوات الملكية إلى المتحف القومي في عام ٢٠٢١ إخترق نزيه مجال العالمية بأن تم ترشيحه لتأليف الموسيقى التصويرية لحلقات مارفل " مون نايت " لشركة ديزني العالمية والتي رشح عنها لجائزة الإيمي العالمية . كما ضمته لجنة جوائز الأوسكار ليكون عضوا دائما في لجان تحكيمها Produced by: Abbas Aboelhassan Follow: rwa.podcast.egInstagram: https://www.instagram.com/rwa.podcast...Facebook: https://web.facebook.com/rwa.podcast.egTwitter: https://twitter.com/rwa_podcast_egTiktok: https://www.tiktok.com/@rwa.podcast.egFollow Abbas Aboelhassan: Instagram: https://www.instagram.com/abbasaboelh...Facebook: https://web.facebook.com/AbbasyzFollow Hesham Nazih:Instagram:https://www.instagram.com/heshamnazih/Facebook: 

Studio Soundtracks takes listeners behind the scenes of how music is crafted for film and television by hearing directly from composers, songwriters and music professionals in the Entertainment Industry. Listen to inspiring conversations about composition and hear works from Emmy, Grammy, and Oscar-winning film scores on the show. Natalie Holt is a multi-award-winning British composer, known for her Emmy-nominated score for Marvel Studios' Loki and the acclaimed Lucasfilm series Obi-Wan Kenobi. Upcoming projects include DC's Batgirl. Her film and television credits include the BAFTA Award-winning series Wallander (BBC), Knightfall (History Channel), the BAFTA Award-winning series Three Girls (BBC), mini-series Deadwater Fell, the Emmy Award-nominated series The Honourable Woman (HBO Max), Victoria (PBS), Saul Dibb's World War I feature Journey's End, Netflix/Claudia Llosa's drama feature Fever Dream, and Fox's female super hero feature The Princess, to name just a few. Natalie's numerous awards nominations and wins include the Primetime Emmy Awards, World Soundtrack Awards' “Television Composer of the Year”, BAFTA, SCL Awards, the Royal Television Society Craft and Design Award, the HMMAs, and “Best International Score” at the Beijing International Film Festival. Hesham Nazih is an award-winning and Emmy-nominated Egyptian composer best known for his unique style that interweaves a mix of melodies from different cultures, creating an authentic genre all his own. He has scored over 40 award-winning films that have dominated the Egyptian box-office such as director Marwan Hamed's musically-intense horror features Blue Elephant and Blue Elephant: Dark Whispers, as well as director Tarek Alarian's Sons of Rizk 1-2, his breakthrough score for Snakes and Ladders, as well as Marwan Hamed's Ibrahim Labyad. Nazih marked his first major English language project with his Emmy-nominated score for Marvel Studios' Moon Knight on Disney+, for which he was also invited to become a member of The Television Academy. He has also composed for critically acclaimed Egyptian television works including The Seven Commandments and Shahid's first original Egyptian series Every Week Has a Friday, which earned Egypt its first-ever International Emmy nomination. Among Nazih's other most notable works, he earned both international attention and acclaim for his original music and songs written for the lavish live production The Pharaohs' Golden Parade in 2021, and he is the first and only composer to ever receive the honorary Faten Hamama Excellence Award from the 2018 Cairo International Film Festival.

Biden set to meet nine Middle East leaders, USIP’s Ambassador Hesham Youssef says the trip aims to untangle recent tensions rather than “result in all kinds of breakthroughs and deliverables … the question is whether we can set ourselves on a path that can lead to more constructive relations.”

In this episode of Frankly Speaking, the Deputy Minister Of Hajj & Umrah Services and Official Spokesperson talks about what it takes to prepare the first Hajj pilgrimage in more than two years and the measures the Ministry is taking to keep people safe during this sacred event.

Helai Hesham is a board-certified doctor of Obstetrics and Gynecology, subspecializing in female pelvic medicine and reconstructive surgery. She is an assistant professor of Female Pelvic Medicine and Reconstructive Surgery at Columbia University Vagelos College of Physicians and Surgeons and completed her fellowship at Harvard Medical School Massachusetts General Hospital. Dr. Hesham sits down with Women on Top with Haleh Moddasser to discuss her experience as a young Afghan refugee, the impact of being raised by a strong female doctor, what Covid revealed about healthcare in the U.S., plus her passion for helping women in poverty.

0:00 SEG 1 Michael Rosenbaum (https://twitter.com/michaelrosenbum) talks about attending FanExpo St. Louis, Superman Celebration in Metropolis, booking guests for his podcast ‘Inside of You with Michael Rosenbaum', losing his grandfather, Steven Amell having an anxiety attack on the podcast, being grateful for his Patrons, what's in store for Superman Celebration, Lex Luther and The Flash crossovers, plans for a Superman animated series with Kristin Kreuk and Tom Welling, appreciating Smallville, meeting Bruce Timm, his favorite item from his collection, stealing Lex Luthor's belongings from the set, and what recent horror films have impressed him. 24:56 SEG 2 Composer Hesham Nazih (https://twitter.com/heshamnazih) talks about making the music for ‘Moon Knigh't on Disney+ 41:32 SEG 3 Part 2 with composer Hesham Nazih Thanks to our sponsors Marcus Theatres (https://www.marcustheatres.com/), Historic St. Charles, Missouri (https://www.discoverstcharles.com/), Bug's Comics and Games (https://bugscomicsandgames.com/), and Kokomo Toys and Collectibles (https://www.kokomotoys.com/) Amazon Affiliate Link - http://bit.ly/geektome Buy Me a Coffee - https://www.buymeacoffee.com/3Y0D2iaZl Patreon - https://www.patreon.com/GeekToMeRadio Website - http://geektomeradio.com/ Podcast - https://anchor.fm/jamesenstall Facebook - https://www.facebook.com/GeekToMeRadio/ Twitter - https://twitter.com/geektomeradio Instagram - https://www.instagram.com/geektomeradio/ Producer - Joseph Vosevich https://twitter.com/Joey_Vee --- Support this podcast: https://anchor.fm/jamesenstall/support

Hesham Nazih is a composer based in Cairo, and the first Egyptian composer to score a Marvel project with MOON KNIGHT. In this interview, Hesham details how he got the job, the spectacular vocal effects in the music, and the difference between the Hollywood sound of Egypt and the real thing — and how they've grown together. Plus, Hesham's story of being unable to afford musical training, and his process of self-teaching from playing in bands to meeting young filmmakers who needed scores. And the lesson one filmmaker shared with him about being unafraid to say “no” when you don't believe in the project. Interview by Matt Schrader.

One of the most heartening things about Disney+'s run of Marvel TV shows is that they seem to be an interesting staging ground for new ideas, the exploration of new communities, and -- most importantly for our interests -- new artists to reach broader audiences. That's certainly the case with Marvel's latest series in the MCU, Moon Knight, which sees Oscar Isaac as Marc Spector/Steven Grant, a pair of dissociative identities sharing the same body, which also happens to be able to summon the spirit of the Egyptian god Khonsu and turn them into the avenging superhero Moon Knight.   The series itself is a brisk, fun Indiana Jones-type adventure, wafting between breezy action sequences and more sobering explorations of the trauma of mental illness, child abuse, and more. But given its Egyptian setting, it's heartening that the vast majority of the talent both in front of and behind the camera are Egyptian, from its director Mohamed Diab to composer Hesham Nazih, a veteran film and TV composer with reams of accolades and more than twenty years of experience in Egyptian media.   For Moon Knight (his first English-language score), Nazih crafts a score that is both indebted to the gee-whiz adventure influences of the show itself and the cultural markers and musical identity of Egypt itself, combining the two into a unique musical synthesis that echoes the balancing scales Marc and Steven have to achieve in order to make themselves whole. Egyptian instruments combing with Arabic-language choir and the bombastic, brass-heavy sweep we expect of superhero blockbusters to create something that feels wholly new, while avoiding the cliches of most Western scores set in the Middle East and North Africa.   For the podcast, Hesham was lovely enough to sit down with me (on the first day of Eid al-Fitr!) to talk about transitioning his robust skill set to Marvel, weaving his own influences within the score while avoiding stereotype, and how his score fits in with the show's use of mahgraganat (a budding genre of exciting, fist-pumping protest music making waves in Cairo the last few years) in the musical fabric of the show.   The entire first (and only?) season of Moon Knight is currently streaming on Disney+. You can also listen to the score for Moon Knight on your preferred music streaming service courtesy of Marvel Music.

3:00 - Jon Watts leaves Fantastic Four 8:00 - Voice Message 1 Doctor Strange 14:48 - Voice Message 2 Wanda Maximoff 25:10 - Gregory Middleton Interview (Cinematographer) 34:30 - Moon Knight Episode 5 Leftovers 1:05:23 - Hesham Nazih (Composer) Interview Learn more about your ad choices. Visit megaphone.fm/adchoices

Children Around The Prophet PBUH (1 Intro) Dr Hesham al Awadi

Hosts Gil Bashe and Gregg Masters welcome two compassionate physicians 'advocating for change.' OB/GYN Jeff Livingston MD and CEO of Macarthur Medical Center and Rush University critical care hospitalist Hesham Hassaballa MD weigh in on the general theme of clinician vulnerability and who heals the healer? Clinician burnout including growing professional exits, staffing shortages and disturbing levels of suicide and depression have reached unprecedented levels as the pandemic continues to take a toll on our frontline clinicians, challenging their emotional, physical and spiritual reserves. Advocating for change, both suggest vulnerability and clinician support systems are critical to the health and wellbeing of clinicians. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Hesham Baalawi is OZ Media's/The Yemeni American News' April Rising Star High School Student-Athlete of the Month.Get to know Hesham. Here is a quick player profile:Name: Hesham BaalawiSchool: Edsel Ford High SchoolSport/Position: Basketball/Point GuardGPA: 4.166The Yemeni American News Article:This episode was sponsored by Unique Coney Island, Fordson Quick Lube and Hammertime True Value Hardware.#Student #athlete #of #the #month #hard #work #dedication #commitment #dearborn #highscool #thunderbirds #dps #ozmedia #yemeniamericannews #youtube #apple #spotify #podcast

Pr. Hesham Shehab of Peace Lutheran-Lombard, IL and Salam Christian Fellowship  

I❤️ARR Podcast with Aditya Modi In this episode, I had the honour of having the amazing Hesham Abdul Wahab. We spoke about his journey, his love and admiration for ARR Sir. This Podcast is all about pure love for ARR Sir. A little note from me - Hesham is one of us. He has worked very hard to get to where he is today. And above all he owes it all to ARR Sir. I highly recommend this Podcast :) I have passionately worked on the post production of this Podcast. It has taken me hours of hard work for this episode. Hope you enjoy :).

First in an series based on the book by Dr. Hesham al-Awadi. Presented by Shaykh Jamaal Diwan.

With Poseidon, Livinia, Hesham, Hasnaa, Jack Bosma and Black from Free4Talk. --- Send in a voice message: https://anchor.fm/jack-bosma3/message Support this podcast: https://anchor.fm/jack-bosma3/support

Aya Hesham Sayed Mohamed is a highly motivated medical student interested in space psychology and a space medicine. Aya looks to combine her medical knowledge with a passion for space innovation. Her experience ranges from authorizing a cross-sectional study about the correlation between traveling to Mars and personality traits to contributing to many international space projects, such as the Collapsible Lower Body Negative Pressure System importance in long-duration missions at University of California. Aya has also been a speaker at international conferences in Egypt, Australia and Mexico. In addition to her vast activity in space medicine entrepreneurship, she was nominated as the first space medicine entrepreneur in Egypt. Her quote of choice is: “If you don't find a path, go and create one”. Aya's dream is to lead an innovative space medicine company and to make space tourism safe and accessible for everyone. --- Support this podcast: https://anchor.fm/spaceexplr/support

دي حلقة استثنائية (لسة قيد الإعداد) بحاول استوعب الصدمة اعذروني...خارج محتوى القناة تماماً الحلقة دي اهداء لروح الصديق العزيز والاخ دكتور هشام عبداللطيف...اللي فارقنا فجأة وكان له افضال كبيرة علي...جايز دة Exposure شخصي ليا بس دة حاجة من اللي اتمنى أذكره بيها والناس تعرفه بيها...فيه ناس فقدها بيشعرك باليتم لمجرد أنهم كانوا سند حقيقي...هشام كان كدة بالنسبة لي ولأي حد عرفه...ادعوا له بالرحمة والمغفرة واتمنى ارثه اللي سابه فيا اقدر اكون سبب في أنه عمله وعلمه يمتد في الدنيا بعدها...الله يرحمك يا هشام --- Send in a voice message: https://podcasters.spotify.com/pod/show/lazy-hypster/message

What is electricity even? Quitting jobs. School sandwiches. A new character: a coach saying "momtaaz!" Why Did I Kill segment: We hate on internet customer service. Drum Rolls Bake Rolz: improvising songs about trapping people in a room, and a poem by Hesham el Gakh. Johnny Cash Walla Credit: Cash complains about laptop updates, bottle caps, and Star Wars.This is episode is sponsored by: Noor ADSL and Savo.يعني إيه كهربا. إستقالة من الشغل. ساندوتشات المدرسة. كاركتر جديدة: مدرب بيقول "ممتاز!" ليه بنكره خدمة العملاء الأنترنت. نرتجل أغاني عن حبس بني آدمين في أوضة، وقصيدة من هشام الجخ. سيجمنت أغاني جوني كاش وهو بيشتكي من تحديثات اللابتوب، وغطى الإزازة، وأفلام حرب النجوم.

On September 23rd, the Pittsburgh Technology Council was in Johnstown, PA to host "Where Electrification and Autonomy Meet: Economic Opportunities and Megatrends in the Automotive Sector." It was an economic forum to explore opportunities associated with two converging megatrends in the global automotive industry: Electrification and Autonomy. Our panelists included national thought leaders from SAE International and the American Iron and Steel Institute. We'll also be hosting some of the fastest growing firms in our region's autonomous vehicle industry, including ARGO, Aurora and Locomation. From the EV supply chain, we heard from local manufacturing firms like PPG and organizations involved in providing EV Infrastructure, including Altoona based Sheetz. TechVibe Radio's Jonathan Kersting interviewed Panelist Hesham Ezzat, Senior Technical Consultant of the Automotive Program, at the American Iron and Steel Institute to learn more about the ever-important roles steel plays in building electric cars. From light-weighting to crash protection there are more than 200 recipes for automotive designers to choose from!

With the 20th Anniversary of the September 11th terror attacks coming up. Nebraska Public Media News reporter William Padmore spoke with members of Nebraska's Islamic community about what it was like growing up in the “9/11 era” of American history. Norhan Basma is a 22-year-old first-generation American and her father, Hesham is 56 and originally from Cairo, Egypt

With the 20th Anniversary of the September 11th terror attacks coming up. Nebraska Public Media News reporter William Padmore spoke with members of Nebraska's Islamic community about what it was like growing up in the “9/11 era” of American history. Norhan Basma is a 22-year-old first-generation American and her father, Hesham is 56 and originally from Cairo, Egypt

104- Héctor Arreaza en Bakersfield, California. Siempre creces al intentar algo nuevo.TEMPORADA 17 - LA SEGUNDA SERIE DELOS EMPRENDEDORES104 -  Héctor Arreaza en Bakersville California. Siempre creces al intentar algo nuevo. 14 de julio de 2021Héctor es médico de familia y tiene siete años viviendo en Estados Unidos. En esta entrevista nos relata sus experiencias como conductor del podcast “Rio Bravo Q-Week” un programa dedicado a la educación médica en idioma inglés. Duración: 28:38///Transcripción (sin corregir)René Mendizábal: 15 de julio de 2021, 7 de la mañana en Toronto, el episodio 104 de los trabajos y los días, continuando con la segunda serie de los emprendedores. Para eso hoy nos acompaña desde Bakersfield en California, el Doctor Héctor Arreaza, médico de familia y creador productor, conductor del podcast Río Bravo Q-Week. Héctor, bienvenido a los trabajos y los días, muchas gracias por aceptar nuestra invitación. Héctor Arreaza: Muchas gracias a ti, René. Para mi es un honor estar aquí contigo conversando, porque soy fiel seguidor de tu podcast y me he divertido mucho con tantos invitados que has tenido. Entonces se me da mucho gusto que me hayas invitado. RLM: Héctor Tú, tú tienes una historia interesantísima en los Estados Unidos que más o menos 14 años, el mismo tiempo que tengo yo en Canadá. Algo similar. Tú saliste de San Juan de los Morros. Estudiaste HA: C. RLM: Medicina en San Juan de los Morros? Te fuiste de misionero a Utah si yo entendí bien nuestra de nuestra última conversación a Salt Lake City. Allí el plan era estar un par de años como misionero. Pero te casaste. Te quedaste. Te reconectarte con la profesión médica. Estando Yuuta y eventualmente una oferta de trabajo te llevó a California, a Bakersfield, en California, con toda la familia. HA: Me correcto. RLM: Y ya tienes años ahí. Tú me contabas que la gente llega a Becca subir pensando que va a estar un rato nada más y ya tú estás echando raíces con todas las de la ley en Bakersfield. HA: C. RLM: Por qué no nos cuentas cómo fue tu llegada? B. Keswick, que fue lo primero que pasó por tu mente cuando llegaste? Y cómo ha sido tu evolución estando allí? HA: Se mira yo llegué a BHS en el año dos mil catorce. Había vivido ya un año en Los Ángeles porque me aceptaron en la Universidad de California, Los Ángeles que seducirle, la universidad muy prestigiosa en California, pero también a nivel mundial. Entonces me aceptaron esa universidad en una de una beca y estuve viviendo en Los Ángeles por un año, casi un año, y me aceptaron un programa de residencia en Medicina Familiar, a quien vacacio. De lo cual estuve muy agradecido porque tuve mucho tiempo tratando de entrar a un posgrado de medicina aquí en Estados Unidos. Porque entrar a un posgrado realmente no es tan fácil. Hay muchos que quizás en Venezuela no están escuchando que que quisieran venir a hacer un posgrado a Estados Unidos. Y bueno, si es posible, porque de hecho todos los años miles de de personas que venimos de otros países logramos entrar a un posgrado aquí, pero es bastante complicado. A mí me tomó ocho años, un poquito se dice fácil, pero para mí fue mucho. Hay personas que lo pueden lograr de repente en seis meses o un año, pero a mí me tomó ocho años RLM: Ok, 8 HA: Porque me RLM: Años HA: Faltaba RLM: Para HA: Quizá. RLM: Entrar en el posgrado y poder comenzar a hacerlo muy bien. Esta oportunidad apareció en Bakersfield. Y cuando uno habla de California hay dos cosas que se le vienen a la mente. Por un lado Hollywood, las estrellas de cine, los estudios y por otro lado la HA: Norma. RLM: Tecnología en San Francisco, Silicon Valley y todo eso. Bakers Will, HA: C. RLM: Como encaja en esos estereotipos que tenemos al calefón? HA: Bueno, Califórnia, como te mencionaba anteriormente, tiene tres divisiones principales. Yo lo llamo los tres paises de California, el país del norte, que es el país que la tecnología de San Francisco de la Bahía. Tenemos el país del Sur, que es donde está Los Angeles, Hollywood y San Diego. Entonces es un país, digamos, el país del sur, el país que más se conoce a nivel mundial y el país del centro, que es el país menos civilizado, quizá con menos desarrollo, donde más que todo tenemos agricultura, ganadería y si somos prácticamente el el, cómo decirlo? El conuco de Estados Unidos, porque aquí es donde se crece o se cultiva todo lo que se consume en este país. O musa de la fruta y la hortaliza y las verduras se consumen pero se cultivan aquí y se consumen tól en todo el país y en muchísimas partes del mundo. Entonces en ese país, en el país del centro, que es el más agrícola, es donde yo me encuentro de cierta forma. Me mudé del estado Guárico, que es un estado agrícola en Venezuela, a un estado agrícola. A quién? A quién? Estados Unidos. Y bueno, vacacio? E tiene una población muy variada, pero la población latinoamericana procede principalmente de México, El Salvador y de Guatemala. Y este este en algunos venezolanos, por más que todos ligados con el área petrolera. Porque también así como me mudé de Venezuela a un país petrolero, me mudé a un condado petrolero aquí que es el condado de Kern. Y aquí algunos venezolanos que están trabajando en el petróleo también. Si. RLM: Entonces hay ganadería, hay petróleo y no tienen nada que ver ni con el cine ni con la tecnología. Es el granero de los Estados Unidos. Y ahí estás tú, ejerciendo medicina como parte de eso. Entonces aparece el podcast Río Bravo IWW Wyck y la primera pregunta sería de dónde sale el nombre? Y después de qué se trata tu podcast? HA: Sí, bueno, Rio Bravo Wyck a Río Bravo. Proviene del nombre que se le dió en español o los españoles. Los conquistadores dieron al río de Kern que el río principal que atraviesa a lo largo de este condado se llamó Río Bravo por los españoles. Ahora se llama Río Cairn, que después los ingleses, al tomar posesión de estas tierras, le dieron otro nombre. Pero entonces el creador, programa de residencia o de posgrado, quería mantener ese ese sabor mexicano, ese sabor latinoamericano. Entonces se mantuvo el el nombre en español Río Bravo. Pero aquí, por supuesto, hay mucha gente que me pregunta si hablamos inglés en el programa. Por supuesto, el programa se sense en inglés porque toda la educación médica que se lleva a cabo en los Estados Unidos se lleva a cabo en inglés. Entonces, esa es la primera parte del nombre Río Bravo. La segunda parte, Keswick, es una es una manera de decir semanalmente en términos médico, cada vez que colocamos la palabra QU€ seguida de una palabra, por ejemplo, un período de tiempo, por ejemplo, Keswick significa semanal qiw day o cada día sería diario. La letra qu 4 horas significa cada 4 horas. Entonces Río Bravo cada semana prácticamente le decimos que es la dosis semanal de conocimiento médico para nuestro residentes y estudiantes de medicina. RLM: Mira, aquí te estoy escuchando, lo tengo en Wikipedia o viene del latín como abreviatura médica de la palabra qwue q.e y quiere cica tantas y tantas horas, cada tantos días, cada tantas semanas. Entonces bueno, aquí que el cu wicket semanalmente, entonces es un podcast semanal. Me imagino que Wyck de que va tu podcast? HA: Si este podcast lo ideamos, no lo ideé pensando exclusivamente en educación médica. Los residentes, mis residentes son de medicina familiar. Yo me inspiré en una conferencia que fui en Portland, Portland, Oregon. Estuve. No, no fue por la NORE y con perdón es la otra ciudad. Bueno, queda en el oeste, en el noroeste de Estados Unidos. Este ya me vanni el nombre, te lo digo. Pero bueno, fui a esa ciudad y estuve en una conferencia médica de educación médica y mucho. Habían muchos, muchos proyectos y a mí me interesó mucho encontrar una manera innovadora de enseñar medicina familiar a mis residentes, a mis estudiantes de medicina. Nadie presentó ninguna edad de pocas, pero pensando en Hesham, en ese formato de que es flexible, de que es fresco, de que es fácil de escuchar, lo puedes poner en cualquier momento. Estás haciendo ejercicio, hasta estás manejando, estás haciendo compras, lo que sea. Entonces dije Bueno, por qué no crear un programa en esta plataforma que le permite al Residente estudiar un tema sencillo, que sea una discusión amena, una discusión interesante y así este tratar de incorporar principios de medicina mientras estamos haciendo cosas cotidianas de la vida cotidiana. Entonces por eso hice ese post, ese podcast y bueno, tuvo muy buena recepción entre los residentes, entre los estudiantes. Quizás el ánimo se ha ido apagando un poco, porque si yo estoy allí siempre pidiéndole por favor, más vamos a hablar de de Errejon y inhalé, vamos a hablar de hipoglicemia, vamos a hablar de de hipermetropía entonse jeje esto se si lo reciente ya había el doctor Arreaza aquí a pedir una que otro tema, pero la verdad es que yo lo disfruto mucho y yo sé que ellos también lo están disfrutando mucho. Entonces hacía muy gratificante para mí, para mi programa, tener ese programa de de pocas. RLM: 2 Escuchó decir que es no es un vodka de entretenimiento, es un podcast sobre educación médica. Es una herramienta, mejor dicho, para educación médica, para beneficio de los residentes, para beneficio de cualquier otro estudiante de medicina o persona interesada. La medicina que hoy lo quiera escuchar me llama mucho la atención que lo hace en idioma inglés y es algo que siempre es fuerte para todos nosotros. Los profesionales que vivimos en otro país nos expresamos en un segundo idioma. Atreverse a a tomar la palestra pública, a hablar en público o salir en un video, dar una presentación, hacer cualquier cosa que implique exponerse comunicándose en el segundo idioma. Cómo fue para ti tomar la decisión de hacer un podcast en tu segundo idioma? Cómo ha sido recibido? Qué desafíos te has encontrado? HA: Se mira no, no fue fácil para mí tomar la decisión, pero. En realidad lo hice porque sentía esa misión personal de educar a no solamente a mi residente, sino a cualquier persona que estuviera escuchando el podcast. Yo sé que me metí en un mercado un poco competitivo porque bueno, no ganamos ningún dinero con eso, pero sí existen muchos podcast médicos de alta calidad aquí en los Estados Unidos, pero yo lo hice con mi programa en mente, pues tenía esa misión personal de poder educar, de brindar un mensaje positivo para mi residente. Por eso decidí hacer y bueno, el acento. Por supuesto, nunca se me va a quitar. Así que dije bueno, qué más lo vamos a hacer. Vamos a ver cómo sale. Y bueno, lo que sí decidí fue hacer un guión. RLM: E. HA: No es como este que estamos haciendo, que sale muy natural, muy con mucho vocabulario propio. Tengo que tener un guión, a pesar de que no lo leo estrictamente palabra por palabra. Si tengo como un esquema de lo que vamos a decir, este y muchos de mis invitados, muchos de mis residentes también son hispanohablantes que tienen inglés como segundo idioma, entre ellos muchos cubanos. Entonces este sí tenemos un guión, el cual no seguimos al pie de la letra, pero sí lo utilizamos como guía. Y fue un desafío, sí, bastante satisfactorio al final, porque es algo diferente a lo que es, como salir de tu área de comodidad, de tu zona de confort y tratar de hacer algo distinto. Y cada vez que uno hace algo distinto, cada vez que uno trata de salir de esa zona de confort, uno siempre crece como persona, como profesional. Entonces pienso que. Que ese sería mi mensaje para para aquellos que están pensando salir de esa zona de confort. Que lo hagan. Que no sientan ese. No sientan vergüenza o no sientan que hay. Que de repente no pueden hacerlo. Porque siempre habrá un crecimiento positivo. Cuando intentas algo nuevo. RLM: Siempre algo positivo cuando intentas algo nuevo. Tú intentaste esto nuevo para ti. Qué satisfacciones entonces te deja? HA: Mira, muchas de muchas satisfacciones. Ya tenemos 60 episodios y de esos yo siento que en cada episodio he aprendido algo nuevo. De hecho, el el slogan que ponemos al final del podcast es eh! Está inspirado en ese refrán que tenemos en español que no te acostarás sin aprender algo más. Entonces siempre aprendo algo nuevo. Soy pro residente. Me enseñan algo a mí y yo le enseñó algo a ellos. Yo siento que es intercambio de opiniones, de información, de ideas. Ha sido lo que más satisfacción me ha traído, de hecho. Como publicamos los guiones, este también me ha servido a mí como un buen centro de referencia para mí mismo, porque a veces, de repente pienso sabes que Claudia Carranza dijo que la hemoglobina tenía que estar en este rango cuando tenemos un una enfermedad renal terminal? Entonces voy y lo busco porque tengo la opción de buscarlo y allí me aparece la información y lo recuerdo. Entonces cierta forma ha sido como mi cuaderno de notas y lo utilizo con frecuencia, de hecho, por lo menos una vez al día. Lo consulto para buscar información que haya salido en el podcast. RLM: Bueno, tienes 60 episodios, eso es muy, muy interesante, muy loable, porque hoy hay podcast de lo que sea y yo conozco gente que ha lanzado un podcast, pero por cantidad habrá gente que pase del décimo episodio con su podcast son muchísimo menos, gente que llegue al episodio número 50 son muchísimos menos. Especialmente porque mucha gente cree que en algún momento o encontrar un esquema de monetización y o tienes muy claro cómo lograr el esquema de monetización o simplemente decidiste que no lo vas a monetizar, que es lo que estás haciendo tú en lo que estoy haciendo yo. Y eso te permite seguir. Por un lado permite seguir, pero por otro lado también te hace preguntarte Vero, por qué estoy haciendo esto? Tú pareces tener esa claridad. Parece que entiendes que es para el beneficio de tu programa de residencia. Es una herramienta de documentación, de enseñanza, de discusión y de práctica, lo cual le da mucha resilencia también a tu proyecto. HA: Si. RLM: Entonces, 60 episodios, cuánto tiempo tiene el podcast cuando lo lanzaste por primera vez? HA: Pero lanzamos por primera vez en marzo de 2020. RLM: Mmmm. HA: Fue justamente la semana antes de que comenzara la pandemia. No teníamos ni idea de que eso iba a suceder. Pero entonces la pandemia en sí fue como un poquito de estamos un poquito como atravesada, sabes? Porque era lo que se hablaba en todas partes. Tú encendías la radio, se veía la televisión, veía un video en Internet Today acerca del color coronà Virus. Y si lo mencionamos en el podcast. Pero no, no tratamos de enfocarnos en ese tema siempre, porque era un tema tan nuevo que decir cualquier cosa. Quizá corría el riesgo de meter la pata prácticamente. Entonces este yo preferí dejar ese tema un poquito al lado, menciona de repente las estadísticas. Cuántos casos había durante esa semana? Desde la cosa que iba saliendo por medio de la Sedes C y todo eso, pero no me enfoqué tanto en el coronà Virus. De hecho, grabamos un episodio de Corona Virus en la segunda semana al podcast. Y sí, efectivamente, como te dije, metimos la pata porque ese momento no se recomendaba usar máscaras, mascarillas, tapabocas. Entonces nosotros allí en esa época recomendamos a la población o a los residentes que no utilizaran tapabocas todavía, porque no se había descubierto que eso era una medida preventiva efectiva. Entonces, más adelante, por supuesto, tuve que ir a hacer alguna edición el escrito y poner allí como información histórica para que la gente sepa de que eso se hizo ya hace mucho tiempo. Entonces, por eso la pandemia quizás no fue el enfoque principal de mi época, sino que nos enfocamos en cosas cotidianas que veíamos normalmente, verdad? Personas con problemas de diabetes, personas con problemas de disfunción eréctil, personas con problemas de ojo rojo, por ejemplo, y así sucesivamente. Son temas muy cotidianos que vemos en el día a día de nuestra práctica médica, nuestro ejercicio médico como médico familiar. Esos son los temas que abordamos allí principalmente. RLM: Ahora tiene que haber sido una gran tentación dedicar el podcast o enfocar el podcast en coronà Virus. Porque precisamente el podcast nace al mismo tiempo que nace toda la situación de pandemia. Hubiera sido una plataforma para hacer otras mucho más conocido. De alguna manera, pero también lo hubiera definido, lo hubiera puesto en una cajita. Cómo tomaron la decisión de resistir esa tentación? HA: Se mira que yo yo escucho muchos podcast médico y cuando yo los escuchaba, ellos presenta las estadísticas, las de Tola, la Pato, fisiología de la enfermedad y los tratamientos que iban surgiendo. Yo me sentía como un poquito inadecuado para abordar esos temas tan profundos y de hecho tengo una amiga que era infectólogo y en algún momento pensé invitarla al programa para para discutir el tema, pero la verdad es que la información que salía era nueva todos los días, o sea, siempre había algo nuevo que contradecía a lo que se había dicho ayer. RLM: Cosas cotidianas de la medicina familiar en Bakersfield, California, el Potas Río Bravo qyue Wyck con Héctor Arreaza, Héctor Si la gente hace esta pregunta posiblemente te la han hecho tú tienes tu familia, tienes tus hijos, tu resposable a actuar. Enseñanza en el programa Residencia Tubo de ejercicio de la medicina normal Te tardaste ocho años en en conseguir un posgrado. Lo conseguiste. Ya has hecho. Rehice. Estableciste tu carrera. Ahora te echas encima la iniciativa del podcast. Por qué tú? Eso a lo mejor lo podía haber hecho otra persona por tú. E inviertes todo este tiempo toda esta energía en esta iniciativa que. Pues sí, a lo mejor se lo podía dejar a un residente para que sea él o cualquier otra cosa. Por qué tenías que ser tú? HA: Sí, mira, yo yo siempre he tenido como mucha curiosidad con la parte audiovisual. Yo nunca he tenido, eh, quizás alguna capacitación en esto y de hecho todas las personas o la mayoría que ve que hace un podcast no tiene mucha experiencia. Pero sí he sido muy curioso en cuanto a transmitir un mensaje. Me gustaba mucho teatro, me gustaba tocar instrumentos, a pesar de que nunca aprendí ningún tipo de instrumento en Venezuela, pero sí tomé clases de teoría y solfeo. Entonces siempre ha sido muy curioso con la parte de lo visual. Y siempre he querido tener un programa, un programa bien sea de radio, de televisión, donde podamos tener opiniones y todo eso. Entonces para mí fue como una oportunidad, ya que tenía los medios, tenía el tiempo, tenía el equipo, no, porque el equipo de hecho te pregunte a ti. Tú fuiste quien me guió para poder comprar el equipo necesario y entonces yo pienso que fue una oportunidad para mí para poder satisfacer ese deseo egoísta de egoísta a la vez altruista, de poder desarrollar un área en el cual siempre he tenido mucho deseo de desarrollarme, a pesar de que no tengo ningún tipo de entrenamiento. Así lo decidí. Por esa razón quería crecer en ese aspecto de la de la de las telecomunicaciones. Cómo lo llamaríamos al área audiovisual? Y por eso lo hice, por una satisfacción personal. RLM: Cuál es el impacto que tiene tu podcast rior a Документы? Wyck Como mi ejes impacto. HA: Mira, el impacto lo podemos dividir en el área personal mía, pero también el cada residente o cada estudiante de medicina que va a discutir conmigo en ese escritorio frente a los micrófonos, un tema en particular. Ellos también tienen un beneficio, pero también sé que muchos tenemos muchos oyentes en otras partes del mundo desde que nos siguen constantemente o que nos siguen regularmente. Entonces, cuando yo veo allí en las estadísticas que alguien nos está escuchando desde Australia o desde el Reino Unido, o de Irlanda, o de muchas otras partes del mundo, incluso en Latinoamérica, me brinda mucha satisfacción. De hecho, a lo publiqué un grupo de WhatsApp que son dos de mis compañeros de clase de la Universidad Universidad Rómulo Gallegos y ellos. Este ZM es comenzar a acosar al Poka, quizá como no lo entienden mucho, pero sí me da mucha satisfacción ver que mi país Venezuela es teníaque muy circulito de personas que me estaban escuchando allí. Entonces el impacto asió, a pesar de que que todo personal para mí y para mi residente también ha tenido un impacto global. Quizás no sea tan tan notorio en este momento, pero a mí por lo menos me da mucha satisfacción que nos escuchen en tantas partes del mundo. Y sí, pienso que ha sido un impacto positivo, tanto para mí como para el resto de las personas que nos escuchan. RLM: Héctor, 14 años en Estados Unidos ya estaban varias en varias zonas de la geografía estadounidense, ha hecho una una gran cantidad de cosas. Si tú pudieras retroceder el tiempo sabiendo las cosas que ya sabes, tú vuelves a elegir Estados Unidos para vivir. HA: Definitivamente, mira. Yo nunca pensé emigrar, como la mayoría de las personas que hemos salido de Venezuela, nunca teníamos esa, esa visión de que en este momento nuestra vida vamos a estar viviendo en otro país. Pero cuando yo pienso en las diferentes opciones que. Qué tendría yo de vivir en diferentes partes del mundo? Pero definitivamente Estados Unidos fue el lugar que me brindó a mí esa esa posibilidad de crecer en la parte humana, en la parte profesional, en la parte familiar. Porque conseguí una esposa maravillosa, que la amo y tengo dos hijos que están creciendo aquí en este país. Y la verdad es que he desarrollado mucho cariño a Estados Unidos en general, a pesar de que sí. Al principio yo pensaba que nunca me iba a ser. Me iba a nacionalizar como ciudadano estadounidense. Pero bueno, debidas a diferentes circunstancias que pasaron a mi vida, lo decidí hacer y es algo de lo cual no me arrepiento. Soy venezolano. Por supuesto, sigo siendo venezolano del Estado Warrick, personal de los Mohr, pero también he Estados Unido ha crecido dentro de mí. He echado raíces y he aprendido a amar a la gente de este país, a las personas que me han tendido una mano amiga, a los lugares donde he vivido, donde resido. Entonces siento que Estados Unidos, el país ideal para mí en este momento. RLM: Bueno, y uno nunca pierde el primer agente, simplemente gana el segundo y crece en esa dirección, pero no significa que el que el anterior se borra simplemente. Pues ahora tienes dos kultura. HA: Claro. Sí, definitivamente. Y y y bueno, como todo extranjero siempre nos asiente de aquí y de allá y de y y todo lo contrario también entonces. Pienso mucho en Venezuela. La guardo muy cerca de mi corazón. Tengo muy lindos recuerdos de mi universidad, de mi niñez en Venezuela. Un lugar tan lindo como Samán de Morros. Tan, tan tranquilo, verdad? Quizás un pueblo, pues comparada con los estándares de otras ciudades en Venezuela. Pero si lo guardo muy cerca al corazón, pero también en mi corazón. Tengo un lugar para Selleck City. Un lugar para Westbury City que queda en Yehudá también Park, Ciri hace y California. Los chanchadas de entonces? Siento que sí. Es una mezcla que pienso que a todos nos pasa, pues tenemos este corazón híbrido, un corazón que está partido en dos. Y bueno, es algo que nos ha tocado vivir. No lo escogimos, pero nos ha tocado vivir y ya. Y a que hay que vivirlo con con la mejor energía posible para lograr lo que uno tiene. Porque yo creo mucho en las misiones, en la vida. Pienso que todos tenemos misiones que tenemos que cumplir. Y si yo cumplí mi misión en Venezuela y quizás en el futuro pueda regresar y cumplir más misiones en Venezuela prontamente en una misión que cumplir aquí en Estados Unidos, una parte educativa enseñará a muchas personas a tocar el corazón de algunas persona, ayudar al desarrollo de algunas áreas porque se trabaja de mucha área en Estados Unidos que están desprovistas de servicios médicos, por ejemplo. Siento que he tenido una misión que cumplir en este país, así como tuve una misión que cumplir en Venezuela en su momento. Y nada, yo estoy aquí disponible para para ser instrumento porque yo soy creyente en Dios e instrumento en la mano de Dios para para brindara felicidad a otras personas, para brindar algún tipo de apoyo y algún tipo de aliento dondequiera que yo me encuentre. RLM: Héctor Ya para terminar, si alguien está siguiendo este podcast quiere empezar a escuchar Río Bravo, Wyck Dónde lo consigue? HA: Nos pueden encontrar en cualquier plataforma de podcast, principalmente a Apopa, Cast, a Google Рамках, pero también en Spotify solamente coloca allí Río Bravo qu wyck como semana en inglés. Allí nos pueden escuchar todas las semanas en inglés. Y bueno, en algún momento voy a grabar algunos episo en español y tengo una amiga venezolana, una colega gastroenterólogo. Espero que ella se anime a poder grabar un episodio conmigo en español y en el futuro quizás tengamos un podcast también desde educación médica en español. Pero eso sí, ya está un poco en veremos porque tengo una amiga peruana que quiere crear un pocas en español. Espero que eso se pueda lograr también. RLM: Perfecto, ojalá que eso suceda muy pronto. Héctor Arreaza en Bakersfield, California, creador y conductor del podcast Río Bravo, qiw Wyck, que está disponible en todas las plataformas para podcast. Gracias por aceptar nuestra invitación, por conversar con nosotros, compartir nuestra experiencia. Ha sido un privilegio para nosotros contar con tu compañía. HA: Igualmente, René, sabes que estoy muy agradecido por todo lo que me ha brindado, porque sí me ha brindado como cierta tutoría gratuita. Me siento muy afortunada haberte encontrado porque así pude arrancar este podcast y pienso que en el futuro quizás tenga que crear un nuevo grupo, una nueva categoría dentro de tu época, que sean tus hijos tecnológicos, porque sé que hay muchas personas por allí que ha asesorado. Entonces pienso que muchos como yo estamos muy agradecido de tu podcast y de la guía que nos ha brindado. RLM: Quiera Dios que si Héctor. Y que sigan los éxitos, que siga la perseverancia y tengamos muchos episodios más de Rio Bravo. Keswick Wyck A nuestra distinguida audiencia agradecerles por su sintonía. Recordarles que los trabajos y los días está disponible en los trabajos y los días puntocom. Todas las aplicaciones para podcast y nuestras redes sociales arroba trabajos días ha sido nuestro episodio 104 y desde Toronto René Mendizabal les desea paz y salud. ///ACERCA DE LOS TRABAJOS Y LOS DÍASLOS TRABAJOS Y LOS DÍAS es el podcast que conecta a los venezolanos globales. Todas las semanas conversamos con venezolanos que viven fuera de Venezuela, para que nos cuenten sus historias migratorias (sus procesos de adaptación, sus experiencias laborales y sus consejos para los próximos migrantes). Cada entrevista que hacemos es en una ciudad diferente del mundo. Nos puedes encontrar todos los martes en www.lostrabajosylosdias.com, y las principales aplicaciones de podcast, a partir de las 7:00 a.m. (Toronto).RSS Feed: https://feeds.transistor.fm/los-trabajos-y-los-diasDATOS DE GRABACIÓNAudio: MP3/Mono/44100Hz/128kbps Consola: Zoom Livetrack L-8 Micrófono: Shure SM7B Edición: Adobe Audition para MacOS Música: Lee Rosevere: Music for Podcasts 1, 3 y 4 Chris Hauge: Front Porch Blues Bleeker Street Blues John Deley: Beer Belly Blues

An international educational podcast for professionals and patients all about the finer details of rhinoplasty. In each episode, we travel the globe talking to world-leading plastic surgeons, hearing their unique stories, and learning from their experiences.

An international educational podcast for professionals and patients all about the finer details of rhinoplasty. In each episode, we travel the globe talking to world-leading plastic surgeons, hearing their unique stories, and learning from their experiences.

Excited to announce the newest addition to the Next Iteration Podcast team, Hesham Nammari! Hesham is our new Head of Growth at the podcast, and we're very excited to be working with him. He's got an interesting story of going viral on LinkedIn off a memepost, so hopefully he can bring that same energy to the podcast team

Pour commander le livre : https://albayyinah.fr/biographies-histoires/3481-des-enfants-autour-du-prophete-hesham-al-awadi-editions-muslimcity-9782491948061.html?lli   

Throwback - BPharm to PharmD to Critical Care to Medication Management Informaticist feat. Dr. Hesham Mourad Intended Audience: Everyone On today's throwback episode. Dr. Hesham Mourad tells us his story of being a pharmacist in Syria and moving to the U.S. to pursue clinical pharmacy, and how that further led him to his current role as a medication management informaticist with a focus on oncology. To connect with Dr. Mourad, visit his LinkedIn: https://www.linkedin.com/in/hesham-mourad-pharmd-bcps-bcccp-aa310655/ Interested in learning more about pharmacy informatics? Check out the FREE Introduction to Pharmacy Informatics course at www.pharmacyinformaticsacademy.com ! New to LinkedIn and not sure where to start? Download my free ebook, "Professional Networking Unlocked", at https://www.tonydaopharmd.com/ebook Follow us on social media! Twitter: @pharmacyitme Instagram: @pharmacyinformatics LinkedIn: https://www.linkedin.com/company/pharmacyitme/ Website: Pharmacy IT & Me Email: tony@pharmacyitme.com Follow Tony's personal Twitter account at @tonydaopharmd Network with other pharmacists at Pharmacists Connect!http://pharmacistsconnect.com For more information on pharmacy informatics, check out some of the following useful links: ASHP's Section of Pharmacy Informatics and Technology: https://www.ashp.org/Pharmacy-Informaticist/Section-of-Pharmacy-Informatics-and-Technology/ HIMSS Pharmacy Informatics Community: https://www.himss.org/library/pharmacy-informatics Disclaimer: Views expressed are my own and do not reflect thoughts and opinions of any entity with which I have been, am now, or will be affiliated. This podcast is powered by Pinecast.

       In this podcast, the entire crew from the GoToDentist Podcast welcomes Dr. Hesham Sherghin onto our virtual set. At just 34 years old, this young dentist has created a phenomenal multilocation dental practice, two other businesses that support practicing dentists, all the while working on his MBA.        You will hear the passion in Hesham's voice, the clarity of his vision, and the business principles he utilizes to manage his time, inspire his team, and make a difference in the lives of his team members as well as his customers.          We were captivated by this young man. Our biggest takeaway was that it really does not matter if you are a small dental practice with 3 team members, or creating a multilocation machine. To have success your vision has to be clear and understandable. The leader has to passionately lead, and when obstacles come (and they will), you must have the persistence to overcome. David, Pio, and John learned a ton from this young professional, we hope you do as well!

Tonight we talk with Alex Winter Director of Deep Web co-hosted by Julia Tourianski. Then we discuss the Paris Attack with Hesham El-Meligy from Muslims4Liberty. We get into misconceptions, Buzz words and general Islamaphobia.

Hesham Abdul Wahab joins us this episode to give insight of his musical career beginnings. He is a young, talented singer/songwriter of Indian decent but grew up in the Middle East. He performs in multiples languages such as Hindi, Urdu, Malayalam and English. Since his introduction to Sami Yusuf's Andante Records in 2011, he has... The post EP 41 – Hesham Abdul Wahab of Andante Records appeared first on Greed for Ilm.